Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,276 public trials 443 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Observational Non-interventional Study With Viramune® in Combination With Truvada® in HIV-infected Patients

NCT00543803

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Boehringer Ingelheim Investigational Site Aachen, Germany
  • 1100.1492.1 Boehringer Ingelheim Investigational Site Berlin, Germany
  • Boehringer Ingelheim Investigational Site 10 Berlin, Germany
  • Boehringer Ingelheim Investigational Site 11 Berlin, Germany
View all 63 locations
View Trial Details
Completed

Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon

NCT01542788

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • SCTI Research Foundation Liver Center Coronado, California, United States
  • Kaiser Permanente Los Angeles, California, United States
  • Lightspeed Medical Los Angeles, California, United States
View all 63 locations
View Trial Details
Completed

Collection of Blood Samples From HIV Infected People

NCT00096772

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Dr. M. Estes Med. Practice CRS Mill Valley, California, United States
  • Dr. Robert Scott Med. Practice CRS Oakland, California, United States
  • East Bay AIDS Ctr. CRS Oakland, California, United States
  • Dr. Shawn Hassler Med. Practice CRS San Francisco, California, United States
View all 83 locations
View Trial Details
Completed

Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in Human Immunodeficiency Virus (HIV)-Infected Children

NCT00076999

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • 1182.14.00001 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
  • 1182.14.00006 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
  • 1182.14.00010 Boehringer Ingelheim Investigational Site Hartford, Connecticut, United States
  • 1182.14.00004 Boehringer Ingelheim Investigational Site Chicago, Illinois, United States
View all 30 locations
View Trial Details

Related conditions